A prediction rule for estimating the risk of bacteremia in patients with community-acquired Pneumonia

Clinical Infectious Diseases

Volumn 49, Issue 3, 2009, Pages 409-416

  Falguera, Miquel ^a   Trujillano, Javier ^b   Caro, Sílvia ^a   Menéndez, Rosario ^d   Carratalà, Jordi ^e   Ruiz González, Agustín ^a   Vilà, Manuel ^c   García, Mercè ^a   Porcel, José Manuel ^a   Torres, Antoni ^f  

^a HOSPITAL UNIVERSITARI ARNAU DE VILANOVA   (Spain)

^b Services of Critical care   (Spain)

^c Services of Pneumology   (Spain)

^d HOSPITAL UNIVERSITARIO LA FE   (Spain)

^e HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^f INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ADULT; AGED; ARTICLE; BACTEREMIA; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; FEMALE; HOSPITAL ADMISSION; HUMAN; HYPOTENSION; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; TACHYCARDIA; TACHYPNEA;

AGED; BACTEREMIA; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; PNEUMONIA, BACTERIAL; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS;

EID: 67651113459     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/600291     Document Type: Article

References (24)

1. Skerrett SJ. Diagnostic testing to establish a microbial cause is helpful in the management of community-acquired pneumonia. Semin Respir Infect 1997; 12:308-21.
2. Luna CM, Famiglietti A, Absi R, et al. Community-acquired pneumonia: etiology, epidemiology, and outcome at a teaching hospital in Argentina. Chest 2000; 118:1344-54.
3. Wattanathum A, Chaoprasong C, Nunthapisud P, et al. Community-acquired pneumonia in Southeast Asia: the microbial differences between ambulatory and hospitalized patients. Chest 2003; 123:1512-9.
4. Sanyal S, Smith PR, Saha AC, Gupta S, Berkowitz L, Homel P. Initial microbiologic studies did not affect outcome in adults hospitalized with community-acquired pneumonia. Am J Respir Crit Care Med 1999; 160: 346-8.
5. Campbell SG, Marrie TJ, Anstey R, Dickinson G, Ackroyd-Stolarz S. The contribution of blood cultures to the clinical management of adult patients admitted to the hospital with community-acquired pneumonia. Chest 2003; 123:1142-50.
6. Waterer GW, Wunderink RG. The influence of the severity of community-acquired pneumonia on the usefulness of blood cultures. Respir Med 2001; 95:78-82.
7. Falguera M, Martín M, Ruiz-González A, Pifarré R, García M. Community-acquired pneumonia as the initial manifestation of serious underlying diseases. Am J Med 2005; 118:378-83.
8. Metersky ML, Ma A, Bratzler DW, Houck PM. Predicting bacteremia in patients with community-acquired pneumonia. Am J Respir Crit Care Med 2004; 169:342-7.
9. Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify lowrisk patients with community-acquired pneumonia. N Engl J Med 1997; 336:243-50.
10. Marrie TJ. Blood cultures in ambulatory patients who are discharged from emergency with community-acquired pneumonia. Can J Infect Dis 2004; 15:21-4.
11. Müller B, Harbarth S, Stolz D, et al. Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia. BMC Infect Dis 2007; 7:10.
12. Barlett JG, Mundy LM. Community-acquired pneumonia. N Engl J Med 1995; 333:1618-24.
13. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007; 44:S27-72.
14. Fernández-Sabe N, Carratalà J, Rosón B, et al. Community-acquired pneumonia in very elderly patients. Causative organisms, clinical manifestations, and outcomes. Medicine 2003; 82:159-69.
15. Falguera M, Pifarré R, Martin M, Sheick A, Moreno A. Etiology and outcome of community-acquired pneumonia in patients with diabetes mellitus. Chest 2005; 128:3233-9.
16. Navasa M, Rodeis J. Bacterial infections in cirrhosis. Liver Int 2004; 24:277-80.
17. Bates DW, Sands K, Miller E, et al. Predicting bacteremia in patients with sepsis syndrome. J Infect Dis 1997; 176:1538-51.
18. Ewig S, Schlochtermeier M, Göke N, Niederman MS. Applying sputum as a diagnostic tool in pneumonia: limited yield, minimal impact on treatment decisions. Chest 2002; 121:1486-92.
19. Marston BJ, Plouffe JF, File TM, et al. Incidence of community-acquired pneumonia requiring hospitalization: results of a population- based active surveillance study in Ohio. Arch Intern Med 1997; 157:1709-18.
20. Dorca J, Manresa F, Esteban L, et al. Efficacy, safety, and therapeutic relevance of transthoracic aspiration with ultrathin needle in nonventilated nosocomial pneumonia. Am J Respir Crit Care Med 1995; 151:1491-6.
21. Ruiz-González A, Falguera M, Vives M, Nogués A, Porcel JM, Rubio-Caballero M. Community-acquired pneumonia: development of a bedside predictive model and scoring system to identify the etiology. Respir Med 2000; 94:505-10.
22. Kauppinen MT, Saikku P, Kujala P, Herva E, Syrjälä H. Clinical picture of community-acquired Chlamydia pneumoniae pneumonia requiring hospital treatment: a comparison between chlamydial and pneumo-coccal pneumonia. Thorax 1996; 51:185-9.
23. Houck PM, Bratzler DW, Nsa W, Ma A, Barlett JG. Timing ofantibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia. Arch Intern Med 2004; 164:637-44.
24. Luna CM. Blood cultures in community-acquired pneumonia: are we readytoquit?Chest 2003; 123:977-8.